Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier

June 4, 2020 updated by: University Hospital, Montpellier

Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier: Follow-up One Month After Discharge From Hospital

This study involves patients who will be discharged from Montpellier University Hospital (acute geriatric care unit) between January and March 2020.

The primary objective is to assess the number of difference(s) in patient's medicines between the discharge from hospital (acute geriatric care unit) and one month after this discharge.

The secondary objectives are:

  • to assess the number of changes of medicines between the patient's admission and discharge from hospital (acute geriatric care unit);
  • to evaluate the number of inappropriate medicines in patient's treatment at hospital admission (in acute geriatric care unit) and one month after the discharge from hospital;
  • to evaluate the number of failures found in the transmission of information between the hospital and the general practitioner/pharmacy one month after the patient's discharge from hospital (acute geriatric care unit).

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • UH Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who will be discharged from hospital (acute geriatric care unit) between January and March 2020

Description

Inclusion Criteria:

  • patients who will be discharged from hospital (acute geriatric care unit) between January and March 2020 and who will return to their home or to institution for elderly persons
  • patients for whom there will be at least one change in their medicines between their admission and their discharge from hospital

Exclusion Criteria:

  • Patients who don't want to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients who will be discharged from hospital (acute geriatric
Patients who will be discharged from hospital (acute geriatric care unit) between January and March 2020

Comparison of patient's medicines:

  • between patient's discharge from hospital and one month after this discharge (acute geriatric care unit)
  • between patient's admission and discharge from hospital (acute geriatric care unit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of medicines prescribed
Time Frame: One month after discharge from hospital (acute geriatric care unit)
Number of medicines prescribed by general practitioner different from those prescribed at patient's discharge from hospital (acute geriatric care unit)
One month after discharge from hospital (acute geriatric care unit)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of medicines' changes
Time Frame: At patient's discharge from hospital (acute geriatric care unit)
Number of changes of medicines between the patient's admission and discharge from hospital (acute geriatric care unit)
At patient's discharge from hospital (acute geriatric care unit)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of inappropriate medicines in patient's treatments
Time Frame: At hospital admission (in acute geriatric care unit)
Number of inappropriate medicines in patient's treatments at hospital admission (in acute geriatric care unit)
At hospital admission (in acute geriatric care unit)
Number of inappropriate medicines in patient's treatments
Time Frame: One month after discharge from hospital (acute geriatric care unit)
Number of inappropriate medicines in patient's treatments one month after discharge from hospital (acute geriatric care unit)
One month after discharge from hospital (acute geriatric care unit)
Number of failures found in the transmission of information between the hospital and the general practitioner/pharmacy
Time Frame: One month after patient's discharge from hospital (acute geriatric care unit)
Number of failures found in the transmission of information between the hospital and the general practitioner/pharmacy one month after the patient's discharge from hospital (acute geriatric care unit)
One month after patient's discharge from hospital (acute geriatric care unit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: DELINGER FAURE, Ph D, UH Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 20, 2020

Primary Completion (ACTUAL)

March 1, 2020

Study Completion (ANTICIPATED)

December 30, 2020

Study Registration Dates

First Submitted

January 2, 2020

First Submitted That Met QC Criteria

January 7, 2020

First Posted (ACTUAL)

January 13, 2020

Study Record Updates

Last Update Posted (ACTUAL)

June 5, 2020

Last Update Submitted That Met QC Criteria

June 4, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL19_0581

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatrics

Clinical Trials on Comparison of patient's medicines

3
Subscribe